From: Eugene Ngai <eugene_ngai**At_Symbol_Here**COMCAST.NET>
Subject: [DCHAS-L] Metal Hydride Gas Medical Treatment for Exposure
Date: Fri, 28 May 2021 14:04:53 -0400
Reply-To: ACS Division of Chemical Health and Safety <DCHAS-L**At_Symbol_Here**Princeton.EDU>
Message-ID: 034f01d753eb$f6b2ec60$e418c520$**At_Symbol_Here**

I coauthored an article on metal hydride gas acute exposures and medical treatment with Steven Curry M.D. (University of Arizona College of Medicine – Phoenix) and George Warpinski, M.D.(Banner – University Medical Center Phoenix) titled “Tox and Hound – Fellow Friday – Metal Hydrides I” This has been a very productive relationship since they are very familiar with toxic affects and medical treatment of these gases while my background is on the manufacturing and use. We all have a total of more than 100 years of experience! We shared a lot of incident information as well as lessons learned. From our archives we shared articles and reports that many have forgotten or are not aware of since some are 40 years old. Some triggered significant change to the way the gas industry packages and/or transports these gases.

I wished we would have collaborated earlier and done some training together.

In this first chapter our focus is primarily on arsine, germane and hydrogen selenide. Future chapters will be on phosphine, diborane and pentaborane.

Please visit the blog to see the article



Eugene Ngai

Chemically Speaking LLC


Previous post   |  Top of Page   |   Next post

The content of this page reflects the personal opinion(s) of the author(s) only, not the American Chemical Society, ILPI, Safety Emporium, or any other party. Use of any information on this page is at the reader's own risk. Unauthorized reproduction of these materials is prohibited. Send questions/comments about the archive to
The maintenance and hosting of the DCHAS-L archive is provided through the generous support of Safety Emporium.